Ligand Pharmaceuticals Statistics
Total Valuation
LGND has a market cap or net worth of $2.19 billion. The enterprise value is $1.99 billion.
| Market Cap | 2.19B |
| Enterprise Value | 1.99B |
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025, after market close.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LGND has 19.29 million shares outstanding. The number of shares has increased by 4.84% in one year.
| Current Share Class | 19.29M |
| Shares Outstanding | 19.29M |
| Shares Change (YoY) | +4.84% |
| Shares Change (QoQ) | +1.14% |
| Owned by Insiders (%) | 2.22% |
| Owned by Institutions (%) | 100.02% |
| Float | 18.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 109.86 |
| PS Ratio | 11.68 |
| Forward PS | 11.20 |
| PB Ratio | 2.75 |
| P/TBV Ratio | 5.03 |
| P/FCF Ratio | 43.05 |
| P/OCF Ratio | 41.48 |
| PEG Ratio | 7.35 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 109.52, with an EV/FCF ratio of 39.04.
| EV / Earnings | n/a |
| EV / Sales | 10.96 |
| EV / EBITDA | 109.52 |
| EV / EBIT | n/a |
| EV / FCF | 39.04 |
Financial Position
The company has a current ratio of 5.27, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.27 |
| Quick Ratio | 4.46 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.23 |
| Debt / FCF | 0.09 |
| Interest Coverage | -4.42 |
Financial Efficiency
Return on equity (ROE) is -16.56% and return on invested capital (ROIC) is -1.29%.
| Return on Equity (ROE) | -16.56% |
| Return on Assets (ROA) | -1.14% |
| Return on Invested Capital (ROIC) | -1.29% |
| Return on Capital Employed (ROCE) | -1.96% |
| Revenue Per Employee | $2.67M |
| Profits Per Employee | -$1.95M |
| Employee Count | 68 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 4.37 |
Taxes
| Income Tax | -28.49M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.53% in the last 52 weeks. The beta is 0.71, so LGND's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | +33.53% |
| 50-Day Moving Average | 108.07 |
| 200-Day Moving Average | 110.47 |
| Relative Strength Index (RSI) | 55.94 |
| Average Volume (20 Days) | 140,889 |
Short Selling Information
The latest short interest is 1.15 million, so 5.98% of the outstanding shares have been sold short.
| Short Interest | 1.15M |
| Short Previous Month | 1.23M |
| Short % of Shares Out | 5.98% |
| Short % of Float | 6.12% |
| Short Ratio (days to cover) | 10.11 |
Income Statement
In the last 12 months, LGND had revenue of $181.49 million and -$132.62 million in losses. Loss per share was -$7.11.
| Revenue | 181.49M |
| Gross Profit | 102.91M |
| Operating Income | -16.63M |
| Pretax Income | 53.01M |
| Net Income | -132.62M |
| EBITDA | 18.16M |
| EBIT | -16.63M |
| Loss Per Share | -$7.11 |
Balance Sheet
The company has $208.90 million in cash and $4.45 million in debt, giving a net cash position of $204.45 million or $10.60 per share.
| Cash & Cash Equivalents | 208.90M |
| Total Debt | 4.45M |
| Net Cash | 204.45M |
| Net Cash Per Share | $10.60 |
| Equity (Book Value) | 795.53M |
| Book Value Per Share | 41.27 |
| Working Capital | 250.63M |
Cash Flow
In the last 12 months, operating cash flow was $52.87 million and capital expenditures -$1.93 million, giving a free cash flow of $50.94 million.
| Operating Cash Flow | 52.87M |
| Capital Expenditures | -1.93M |
| Free Cash Flow | 50.94M |
| FCF Per Share | $2.64 |
Margins
Gross margin is 56.70%, with operating and profit margins of -9.16% and -73.07%.
| Gross Margin | 56.70% |
| Operating Margin | -9.16% |
| Pretax Margin | -88.77% |
| Profit Margin | -73.07% |
| EBITDA Margin | 10.00% |
| EBIT Margin | -9.16% |
| FCF Margin | 28.07% |
Dividends & Yields
LGND does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.84% |
| Shareholder Yield | -4.84% |
| Earnings Yield | -6.05% |
| FCF Yield | 2.32% |
Analyst Forecast
The average price target for LGND is $144.71, which is 27.72% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $144.71 |
| Price Target Difference | 27.72% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 17.32% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 19, 2010. It was a reverse split with a ratio of 0.16666:1.
| Last Split Date | Nov 19, 2010 |
| Split Type | Reverse |
| Split Ratio | 0.16666:1 |
Scores
LGND has an Altman Z-Score of 11.41 and a Piotroski F-Score of 3.
| Altman Z-Score | 11.41 |
| Piotroski F-Score | 3 |